Urinary Bladder, Overactive: all 864 studies

Page 4 of 9. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00461292Phase 3Results posted
• Overactive Bladder Innovative Therapy Trial (OrBIT)CompletedNCT00448175Phase 4Results posted
• Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)CompletedNCT00444925Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderTerminatedNCT00439140Phase 3Results posted
• Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)CompletedNCT00431041Phase 4Results posted
• Local Anesthetic Treatments for Overactive BladderTerminatedNCT00427648Phase 3Results posted
• A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder PatientsCompletedNCT00425100Phase 3Results posted
• SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)CompletedNCT00409539Phase 2Results posted
• A Comparison of a New Drug to Treat Overactive Bladder vs. PlaceboCompletedNCT00350636Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive BladderCompletedNCT00311376Phase 3Results posted
• A Research Study for Patients With Overactive BladderCompletedNCT00168454Phase 2Results posted
• An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency SyndromeCompletedNCT00131573Phase 3Results posted
• Effect of Antimuscarinic Treatment on Premature Ejaculation Severity in Men With Overactive Bladder: a Prospective Comparison With MirabegronCompletedNCT07736560
• Bladder Training With or Without Biofeedback-Assisted Pelvic Floor Muscle Training for Women With Wet Overactive BladderCompletedNCT07728747Not applicable
• SGLT-2 Inhibitors and Lower Urinary Tract SymptomsActive, not recruitingNCT07716774
• Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year StudyActive, not recruitingNCT07693192Not applicable
• Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder SymptomsActive, not recruitingNCT07554989
• The New Possibility of Treating Overactive Bladder With RadiofrequencyCompletedNCT07398014Not applicable
• TTNS vs PTNS in a County Hospital System.CompletedNCT07353944Not applicable
• Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined PharmacotherapyCompletedNCT07337252
• Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in FemalesCompletedNCT07312955Not applicable
• Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority TrialActive, not recruitingNCT07259148Not applicable
• A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve TrialCompletedNCT07206446Not applicable
• Moving Beyond p-Values: MCID for OAB-V8 8 and ICIQ-SF in Patients With OABCompletedNCT07171424Not applicable
• Transdermal Versus Oral Oxybutynin in Pediatric OABCompletedNCT07081906Not applicable
• Treatment of Overactive Bladder With Anticholinergic AgentsActive, not recruitingNCT07046156
• Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of LifeCompletedNCT07044778
• Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder FunctionCompletedNCT06944392Not applicable
• Efficacy of Animated Videos to Foster Healthy Bladder Behaviors in Community WomenCompletedNCT06921915Not applicable
• Ease of Use Study of the FemPulse SystemCompletedNCT06885099Not applicable
• Evaluation of the Tensi+ Device for the Treatment of Overactive BladderCompletedNCT06847789
• Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation Vs Botulinum Toxin InjectionsCompletedNCT06796855Phase 4
• The Role of Urinary ATP in the Diagnosis, Treatment, and Follow-up of Children with Overactive BladderCompletedNCT06785558Not applicable
• Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive BladderCompletedNCT06780163Phase 4
• Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1CompletedNCT06616675Phase 4
• Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)CompletedNCT06569342
• Real-life Clinical Experience With Ialuadapter StudyCompletedNCT06540248
• Prophylactic Analgesia for Bladder Botox InjectionsWithdrawnNCT06514430Phase 4
• Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal WomenCompletedNCT06508944Phase 4
• Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic BiomarkerCompletedNCT06489951Not applicable
• Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive BladderCompletedNCT06484023
• Transvaginal Radiofrequency Ablation for Overactive BladderCompletedNCT06458556Not applicable
• Usability Study of the FemPulse SystemCompletedNCT06347380Not applicable
• Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female SubjectsCompletedNCT06345677Not applicable
• NXT Post-Market Clinical Follow-upTerminatedNCT06336304
• Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive BladderCompletedNCT06250543Phase 4
• Evaluation of the Efficacy of Transcutaneous Tibial Nerve Stimulation on Post-Stroke Overactive BladderCompletedNCT06247033Not applicable
• Association With Low Compliance Bladder in Women With LUTSCompletedNCT06210477
• Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive BladderCompletedNCT06206512Phase 2
• rTMS in Overactive BladderCompletedNCT06198439Not applicable
• Management of OAB in Female Patients .CompletedNCT06184334Not applicable
• Acupuncture Combined With Mirabegron in the Treatment of OABActive, not recruitingNCT06181019Phase 1
• Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive BladderCompletedNCT06123364Not applicable
• Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)Active, not recruitingNCT06110975Not applicable
• Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive BladderCompletedNCT06024005Not applicable
• Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive BladderActive, not recruitingNCT05977634Not applicable
• Virtual Reality (VR) During Peripheral Nerve Evaluation (PNE) ProcedureWithdrawnNCT05928910Not applicable
• Yoga for Treatment of Overactive Bladder in Pediatric PatientsTerminatedNCT05895045Not applicable
• Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of FallsCompletedNCT05880862Early Phase 1
• Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder SymptomsActive, not recruitingNCT05878951Phase 2/3
• Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) LeadCompletedNCT05799313Not applicable
• Mobile Application and Bladder TrainingCompletedNCT05792956Not applicable
• Effect of Mirabegron on Bladder ComplianceStatus unknownNCT05745584Not applicable
• Wearables for the Bladder: an In-home Treatment Feasibility Pilot StudyActive, not recruitingNCT05715268Not applicable
• Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in ChildrenCompletedNCT05709990Not applicable
• Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .CompletedNCT05702294Not applicable
• Trial for Reliability of Urodynamics SysTemCompletedNCT05694793Not applicable
• Sacral Neuromodulation in Neurogenic PatientsStatus unknownNCT05688644
• Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor in Women With Overactive BladderCompletedNCT05677841Not applicable
• Comparison of the Effects of External Electrical Stimulation Protocols in Women With Overactive BladderStatus unknownNCT05672290Not applicable
• Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive BladderStatus unknownNCT05672277Not applicable
• Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive BladderStatus unknownNCT05668715Not applicable
• Is Elective Caesarean Sections for Predicting Post-spinal Hypotension Role of Overactive Bladder?CompletedNCT05624671Not applicable
• Codesign of an Optical Device to Measure Urine Flow and VolumeStatus unknownNCT05576311
• Developing a Simple Test to Diagnose Overactive BladderStatus unknownNCT05572918
• Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 WeeksCompletedNCT05557279Phase 2
• Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in StrokeCompletedNCT05557175Not applicable
• A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary IncontinenceActive, not recruitingNCT05534412Not applicable
• Reduced-dose Botox for Urgency Incontinence Among Elder FemalesActive, not recruitingNCT05512039Phase 1/2
• Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OABStatus unknownNCT05494567Phase 4
• Virtual Bladder Training for Overactive Bladder Syndrome in Women. Which Symptom Responds Better?Status unknownNCT05493748Not applicable
• Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in AdultsCompletedNCT05464589Not applicable
• Transvaginal Botulinum Toxin A Chemodenervation for Overactive BladderCompletedNCT05463822Early Phase 1
• Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical StudyStatus unknownNCT05452434Phase 4
• The Efficacy of Intravaginal Electrical Stimulation in Women With Idiopathic Overactive BladderStatus unknownNCT05416450Not applicable
• The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the BladderStatus unknownNCT05415865Phase 3
• The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive BladderWithdrawnNCT05393921Phase 4
• Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive BladderStatus unknownNCT05387824Not applicable
• A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive BladderTerminatedNCT05381116Not applicable
• Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)CompletedNCT05368246Not applicable
• Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor DysfunctionStatus unknownNCT05337813Not applicable
• Nerve Stimulation Using a TENS to Provide Pain Relief During Surgery for Overactive BladderCompletedNCT05330117Not applicable
• Targeting Microbiota in Female Overactive Bladder SyndromeStatus unknownNCT05328011
• OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation.CompletedNCT05313984
• Multiple Sclerosis and Overactive Bladder TreatmentCompletedNCT05312138Not applicable
• INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive BladderWithdrawnNCT05309993Not applicable
• A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive BladderCompletedNCT05282069Phase 3
• AURA 1: Augmenting Urinary Reflex Activity: Study 1WithdrawnNCT05256498Not applicable
• INTIBIA Pivotal StudyActive, not recruitingNCT05250908Not applicable
• Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea SyndromeCompletedNCT05250245Phase 4

← Urinary Bladder, Overactive overview